Fedha

Hisa unazofuatilia
Kwa nini CRSP imepungua kwa 6.21%?
Fahamu zaidi
CRSP:NASDAQ
Crispr Therapeutics AG
US$ 48.56
-6.21%
(-3.22) Siku 1
US$ 48.90
+0.70% (+0.34)
Kabla ya soko
Imefungwa: 5 Nov, 16:00:00 GMT -5  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya CRSP...
Fungua
US$ 51.01
Juu
US$ 51.21
Chini
US$ 47.76
Mtaji wa soko
4.71B
Wastani wa kiasi cha mauzo
1.44M
Kiasi cha mauzo ya hisa
elfu 1.67
Juu kwa wiki 52
US$ 63.45
Chini kwa wiki 52
US$ 44.12
EPS
-US$ 4.75
Beta
1.49
Hisa za wawekezaji
97.00M
Idadi ya wafanyakazi
393
Fungua
US$ 51.01
Juu
US$ 51.21
Chini
US$ 47.76
Mtaji wa soko
4.71B
Wastani wa kiasi cha mauzo
1.44M
Kiasi cha mauzo ya hisa
elfu 1.67
Juu kwa wiki 52
US$ 63.45
Chini kwa wiki 52
US$ 44.12
EPS
-US$ 4.75
Beta
1.49
Hisa za wawekezaji
97.00M
Idadi ya wafanyakazi
393
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
Kuhusu Crispr Therapeutics AG
Afisa Mkuu Mtendaji (CEO)Samarth Kulkarni
Wafanyakazi393
Lilianzishwa2013
Makao makuuZug, Jimbo la Zug, Uswisi
SektaHealth Care
Industry-
Tovuticrisprtx.com
Ukadiriaji wa mchanganuzi
Kulingana na wachanganuzi 14 waliotoa ukadiriaji wa hisa kwa CRSP katika miezi 3 iliyopita
Nunua
Nunua
8
Shikilia
6
Uza
0
Utabiri wa miezi 12
Kulingana na wachanganuzi 14 wa Wall Street wanaotoa makadirio ya bei ya miezi 12 ya CRSP katika miezi 3 iliyopita.
Juu kabisa
Ya sasa US$ 48.56
US$ 110.00 (+126.52%)
Wastani
US$ 70.83 (+45.86%)
Chini kabisa
US$ 45.00 (-7.33%)
Mchanganuzi
Unaopendekezwa
Kitendo
Bei lengwa
Unaokadiriwa
Tarehe
Alec Stranahan
Bank of America Securities
Buy
Maintained
US$ 80.00
+64.7%
11/04/2026
Yigal Nochomovitz
Citi
Buy
Maintained
US$ 90.00
+85.3%
11/04/2026
Yanan Zhu
Wells Fargo
Hold
Reiterated
US$ 70.00
+44.2%
11/04/2026
Luca Issi
RBC Capital
Hold
Maintained
US$ 50.00
+3%
11/03/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
US$ 80.00
+64.7%
11/04/2026
Joon Lee
UBS
Hold
Maintained
US$ 52.00
+7.1%
11/03/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
US$ 110.00
+126.5%
11/03/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
-
-
11/03/2026
Tyler Van Buren
TD Cowen
Hold
Maintained
US$ 45.00
-7.3%
10/21/2026
Gil Blum
Needham
Buy
Maintained
US$ 82.00
+68.9%
10/05/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
US$ 76.00
+56.5%
08/31/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/28/2026
Maxwell Skor
Morgan Stanley
Hold
Maintained
US$ 60.00
+23.6%
08/28/2026
Salveen Richter
Goldman Sachs
Hold
Reiterated
US$ 55.00
+13.3%
08/10/2026
Unknown Analyst
Goldman Sachs
Hold
Maintained
US$ 55.00
+13.3%
08/06/2026
Terence Flynn
Morgan Stanley
Hold
Maintained
US$ 60.00
+23.6%
08/04/2026
Silvan Turkcan
Citizens JMP
Buy
Maintained
US$ 80.00
+64.7%
07/22/2026
Unknown Analyst
Mizuho Securities
Buy
Maintained
US$ 85.00
+75%
06/10/2026
William Pickering
Bernstein
Hold
Reiterated
US$ 56.00
+15.3%
05/13/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
US$ 76.00
+56.5%
05/04/2026
Silvan Tuerkcan
Citizens JMP
Buy
Maintained
US$ 80.00
+64.7%
01/30/2026
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Des 2025
Mac 2026
Jun 2026
Sep 2026
Mapato
elfu 864.00
1.46M
10.18M
12.67M
Gharama ya bidhaa zilizouzwa
137.23M
114.52M
107.42M
113.17M
Gharama ya mapato
137.23M
114.52M
107.42M
113.17M
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
18.40M
17.18M
17.55M
17.87M
Gharama ya uendeshaji
18.40M
17.18M
17.55M
17.87M
Jumla ya gharama za uendeshaji
155.63M
131.71M
124.98M
131.04M
Mapato ya uendeshaji
-154.76M
-130.25M
-114.80M
-118.37M
Mapato mengine yasiyo ya uendeshaji
24.76M
8.16M
27.08M
18.68M
EBT ikijumuisha vipengee visivyo vya kawaida
-130.00M
-122.09M
-90.19M
-111.36M
EBT bila kujumuisha vipengee visivyo vya kawaida
-130.00M
-122.09M
-87.72M
-99.69M
Gharama ya kodi ya mapato
elfu 614.00
elfu 839.00
elfu 960.00
elfu 74.00
Kiwango cha kodi kinachotumika
-0.47%
-0.69%
-1.06%
-0.07%
Gharama nyingine za uendeshaji
-
-
-
-
Mapato halisi
-130.61M
-122.93M
-91.15M
-111.44M
Kiwango cha faida halisi
-15,117.25%
-8,431.48%
-895.33%
-879.60%
Mapato kwa kila hisa
-1.37
-1.28
-0.94
-1.15
Mapato ya riba na uwekezaji
-
-
-
-
Gharama ya riba
-
-
-
-
Jumla ya gharama halisi za riba
-
-
-
-
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
-149.10M
-125.93M
-110.52M
-114.13M
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Miamala ya wajuzi wa mambo
Data ya miamala ya watu wenye hisa hutolewa kwenye vyanzo vya washirika wengine. Pata maelezo zaidi
Mjuzi wa mambo
Nafasi
Aina
Tarehe
Hisa
Kiasi
Ukurasa wa 1
Matukio yajayo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho
Programu za Google